The Male Health Study

The study is exploring a potential new treatment for Prostate Cancer. Prostate cancer is a commonly diagnosed cancer for men across Australia and the 5th leading cause of cancer-related death for men.

The study drug will be administered via an oral tablet. Participants will receive one dose.
Through oral administration, the main aim is to overcome resistance to other treatments with the expectation of good absorption and safety, making it a potential anti-tumor drug for prostate cancer.

The trial has been approved by an independent ethics committee, and eligible participants will be reimbursed for their time.

Call us at 1800 243 733 to discuss your eligibility today!